Alamar Biosciences, INC. (ALMR) — SEC Filings
Latest SEC filings for Alamar Biosciences, INC.. Recent CERT filing on Apr 16, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
Overview
Alamar Biosciences, INC. (ALMR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a CERT filed on Apr 16, 2026: Alamar Biosciences, Inc. filed a CERT form on April 16, 2026, to certify the approval of securities for listing. The filing, with SEC Accession No. 0001354457-26-000353, indicates that the effectiveness date for this approval is also April 16, 2026. The company's mailing and business address is 4707
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant filing sentiment for Alamar Biosciences, INC. is neutral.
Filing Type Overview
Alamar Biosciences, INC. (ALMR) has filed 1 CERT, 1 S-1/A with the SEC between Apr 2026.
Recent Filings (2)
-
Alamar Biosciences Certifies Securities Listing Approval
— CERT · Apr 16, 2026 Risk: low
Alamar Biosciences, Inc. filed a CERT form on April 16, 2026, to certify the approval of securities for listing. The filing, with SEC Accession No. 0001354457-2 -
Alamar Biosciences Files S-1/A for Securities Registration
— S-1/A · Apr 13, 2026 Risk: medium
Alamar Biosciences, Inc. filed an S-1/A amendment on April 13, 2026. This filing is a general form for the registration of securities under the Securities Act o
Frequently Asked Questions
What are the latest SEC filings for Alamar Biosciences, INC. (ALMR)?
Alamar Biosciences, INC. has 2 recent SEC filings from Apr 2026, including 1 CERT, 1 S-1/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ALMR filings?
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant sentiment is neutral.
Where can I find Alamar Biosciences, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Alamar Biosciences, INC. (ALMR) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.